Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Amortizatization of Intangibles: 2020-2025

Historic Amortizatization of Intangibles for Relay Therapeutics (RLAY) over the last 6 years, with Sep 2025 value amounting to $1.1 million.

  • Relay Therapeutics' Amortizatization of Intangibles fell 65.36% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 54.55%. This contributed to the annual value of $12.3 million for FY2024, which is 14.42% up from last year.
  • According to the latest figures from Q3 2025, Relay Therapeutics' Amortizatization of Intangibles is $1.1 million, which was down 21.02% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Relay Therapeutics' Amortizatization of Intangibles ranged from a high of $3.7 million in Q4 2023 and a low of -$681,000 during Q4 2021.
  • Over the past 3 years, Relay Therapeutics' median Amortizatization of Intangibles value was $2.2 million (recorded in 2023), while the average stood at $2.5 million.
  • In the last 5 years, Relay Therapeutics' Amortizatization of Intangibles slumped by 8,275.00% in 2021 and then surged by 945.88% in 2023.
  • Over the past 5 years, Relay Therapeutics' Amortizatization of Intangibles (Quarterly) stood at -$681,000 in 2021, then soared by 156.53% to $385,000 in 2022, then skyrocketed by 852.99% to $3.7 million in 2023, then plummeted by 40.56% to $2.2 million in 2024, then plummeted by 65.36% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.4 million for Q2 2025, and $1.6 million during Q1 2025.